Sera Prognostics sees PreTRM test volume surge five-fold from Q1 levels, bolstered by a 34% increase in ordering providers and new Medicaid coverage in Florida.
On Nov 4, 2026, Sera Prognostics reported Q3 2026 results showing PreTRM test volume up 54% sequentially and about five-fold from 1Q26, with ordering providers up 34% sequentially; Florida became the second Medicaid state covering the test. These operational gains support a positive reaction, though the excerpt lacks revenue or profit figures to confirm the financial impact.
PreTRM test volume increased 54% sequentially and about five-fold from 1Q26, while ordering healthcare providers rose 34% sequentially.
Florida became the second Medicaid state to cover the PreTRM test.
Sera Prognostics reported significant operational momentum for the third quarter of 2026, highlighted by a 54% sequential increase in PreTRM test volume. The company also expanded its market reach as Florida became the second state to provide Medicaid coverage for the diagnostic test.
Growth was driven by a 54% sequential increase in PreTRM test volume and a 34% rise in the number of ordering healthcare providers.
Florida became the second state to provide Medicaid coverage for the PreTRM test, expanding the company's access to public health insurance markets.